Latest stories on BCYC
Bicycle Therapeutics: Trading Below Cash Amid Multiple Uncertainties
Seeking Alpha42 · neutralanalyst
Bicycle Therapeutics Reports Positive Duravelo-2 Phase 2 Data
TipRanks67 · bullishproduct/pr
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting | BCYC Stock News
StockTitan67 · bullishproduct/pr